Chronic intrahypothalamic rather than subcutaneous liraglutide treatment reduces body weight gain and stimulates the melanocortin receptor system (scientific article published on 25 April 2017)

scientific article published on 25 April 2017

Chronic intrahypothalamic rather than subcutaneous liraglutide treatment reduces body weight gain and stimulates the melanocortin receptor system is …

instance of (P31):

scholarly article

Q13442814

External links are

P6179	Dimensions Publication ID	1085415817
P356	DOI	10.1038/IJO.2017.98
P932	PMC publication ID	5550563
P698	PubMed publication ID	28507313

P50

author

Bolette Hartmann

Q51055821

Katrin Kaineder

Q64495799

Selma Mautner

Q90224789

Signe Sørensen Torekov

Q38548255

P2093

author name string

J Eichler

T R Pieber

B Obermüller

G Rauter

J Münzker

P Kotzbeck

T Birngruber

W Al-Zoughbi

P2860

cites work

Transfer of liraglutide from blood to cerebrospinal fluid is minimal in patients with type 2 diabetes

Q58447447

The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans

Q58448806

Glucagon-like Peptide-1 receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake and motivation to feed

Q41816012

Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice

Q42004480

Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.

Q42445138

Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway

Q42492353

Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans

Q42612217

Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight

Q42936904

Melanocortin activity in the amygdala controls appetite for dietary fat.

Q43239280

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

Q43255700

One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.

Q44865459

GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.

Q46088562

Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function

Q47237643

Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat.

Q47273005

Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats.

Q47295180

Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not.

Q47308234

Liraglutide: short-lived effect on gastric emptying -- long lasting effects on body weight

Q47333623

Long-term persistence of hormonal adaptations to weight loss

Q47347342

Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats

Q47385994

Gene expression of pro-opiomelanocortin and melanocortin receptors is regulated in the hypothalamus and mesocorticolimbic system following nicotine administration

Q48415551

Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats

Q48905629

A role for glucagon-like peptide-1 in the central regulation of feeding

Q24314317

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Q25938999

Melanocortin 4 receptor activates ERK-cFos pathway to increase brain-derived neurotrophic factor expression in rat astrocytes and hypothalamus

Q28260767

Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human

Q29617382

Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect

Q30412673

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

Q30596646

Quantification of adiposity in small rodents using micro-CT

Q33635804

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

Q33737073

Differences in acute anorectic effects of long-acting GLP-1 receptor agonists in rats.

Q33959406

Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic [...]

Q34089543

Brown and beige fat: development, function and therapeutic potential

Q34375850

Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice

Q34428994

Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss.

Q34665186

Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.

Q35110843

Long-term implanted cOFM probe causes minimal tissue reaction in the brain

Q35118715

Leptin reverses declines in satiation in weight-reduced obese humans

Q35677267

GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake

Q35744558

Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity

Q35768964

Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling

Q36339639

Adaptive thermogenesis in humans